Merit Medical Systems Inc
NASDAQ:MMSI
Intrinsic Value
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. [ Read More ]
The intrinsic value of one
MMSI
stock under the Base Case scenario is
75.13
USD.
Compared to the current market price of 73.38 USD,
Merit Medical Systems Inc
is
Undervalued by 2%.
Merit Medical Systems Inc's market capitalization is 4.2B USD.
MMSI stock price is 73.38 USD.
MMSI stock price (73.38 USD) is 2% less than its Intrinsic Value (75.13 USD).
MMSI stock price (73.38 USD) is 29% less than its Relative Value (102.63 USD). Open Relative Valuation
MMSI has upside potential of 30% compared to the average analyst price target.
Open Wall St Estimates
MMSI's ROE (Return on Equity) for the past 12 months is positive and is equal to 8%.
MMSI's Revenue has grown by 9% over the past 12 months.
MMSI has positive Operating Income for the last twelve months.
MMSI's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 7%.
MMSI's Revenue is forecast to grow at a rate of 6% per year over the next 3 years.
MMSI has positive Net Debt. This means that the company has more debt (823m USD) than cash and short-term investments (587m USD).
MMSI's ROIC (Return on Invested Capital) has decreased in the last 3 years from 12% to 7%.
MMSI has positive Net Income for the last twelve months.
MMSI's ROE (Return on Equity) has increased in the last 3 years from 0% to 8%.
MMSI's Revenue has been growing by 9% per year for the last 3 years.
MMSI has positive three-year average ROIC (Return on Invested Capital): 6%. The company is efficient at using invested capital to generate operating income.
MMSI has positive three-year average ROE (Return on Equity): 5%. The company is efficient at transforming stockholders' equity into net income.
MMSI has positive Free Cash Flow for the last twelve months.
MMSI generates enough operating income (124m USD) to cover interest payments on its debt (14m USD).
MMSI's D/E (Debt to Equity) is very low and is equal to 0.68.
MMSI's long-term assets (2B USD) exceed its long-term liabilties (1B USD).
MMSI has positive Gross Profit for the last twelve months.
MMSI's Altman Z-Score is very high and is equal to 3.58.
MMSI's short-term assets (1B USD) exceed its short-term liabilties (204m USD).
Valuation Backtest
Merit Medical Systems Inc
Run backtest to discover the historical profit from buying and selling
MMSI
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Merit Medical Systems Inc
Balance Sheet Decomposition
Merit Medical Systems Inc
| Current Assets | 1.1B |
| Cash & Short-Term Investments | 587m |
| Receivables | 189.3m |
| Other Current Assets | 332.2m |
| Non-Current Assets | 1.2B |
| PP&E | 446.6m |
| Intangibles | 708.1m |
| Other Non-Current Assets | 62.1m |
| Current Liabilities | 203.6m |
| Accounts Payable | 65.9m |
| Accrued Liabilities | 132.5m |
| Other Current Liabilities | 5.1m |
| Non-Current Liabilities | 919.7m |
| Long-Term Debt | 823m |
| Other Non-Current Liabilities | 96.7m |
Earnings Waterfall
Merit Medical Systems Inc
|
Revenue
|
1.3B
USD
|
|
Cost of Revenue
|
-673.5m
USD
|
|
Gross Profit
|
583.9m
USD
|
|
Operating Expenses
|
-459.7m
USD
|
|
Operating Income
|
124.2m
USD
|
|
Other Expenses
|
-29.8m
USD
|
|
Net Income
|
94.4m
USD
|
Free Cash Flow Analysis
Merit Medical Systems Inc
MMSI Profitability Score
Profitability Due Diligence
Merit Medical Systems Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Merit Medical Systems Inc's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
MMSI Solvency Score
Solvency Due Diligence
Merit Medical Systems Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Merit Medical Systems Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MMSI Price Targets Summary
Merit Medical Systems Inc
According to Wall Street analysts, the average 1-year price target for
MMSI
is 95.47 USD
with a low forecast of 85.85 USD and a high forecast of 117.6 USD.
Ownership
MMSI Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
MMSI Price
Merit Medical Systems Inc
| Average Annual Return | 14.26% |
| Standard Deviation of Annual Returns | 47.77% |
| Max Drawdown | -66% |
| Market Capitalization | 4.2B USD |
| Shares Outstanding | 58 385 000 |
| Percentage of Shares Shorted | 5% |
Company Profile
Merit Medical Systems Inc
Country
Industry
Market Cap
Dividend Yield
Description
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. The company is headquartered in South Jordan, Utah and currently employs 6,446 full-time employees. The Company’s segments include cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, interventional oncology and spine devices. The endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products, including peripheral intervention, cardiac intervention, custom procedural solutions, original equipment manufacturer and endoscopy.
Contact
IPO
Employees
Officers
The intrinsic value of one
MMSI
stock under the Base Case scenario is
75.13
USD.
Compared to the current market price of 73.38 USD,
Merit Medical Systems Inc
is
Undervalued by 2%.
You don't have any saved screeners yet
